Radioterapia para la oligorrecurrencia en cáncer de próstata. Resultados preliminares en nuestro centro.

Our data suggest that the use of SBRT in carefully selected patients with metastatic oligorecurrence of prostate cancer can achieve biochemical response and potentially delay progression and the use of systemic treatments.